Page 6 - Andreas Bergmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-News: Proen ... DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients vom 16.12.2020, 10:00 Uhr Bild: pixabay.com DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely responsible for the content of this announcement. The latest consensus meeting of international experts i...

Press release content from Accesswire. The AP news staff was not involved in its creation. Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients December 16, 2020 GMT The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice Proenkephalin (pen...

(1) DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely responsible for the content of this announcement. The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with c...

Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice Proenkephalin (penKid®), the kidney function biomarker, proposed as a marker for the assessment of AKI progression and kidney r...

 E-Mail Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise The biomarkers for the real-time assessment of kidney function (penKid®) and endothelial function (bio-ADM®) are pioneering new diagnostic pathways in critical care settings Following a positive initial clinical evaluation of penKid® and bio-ADM®, the University Hospital RWTH Aachen has transferred the innovative diagnostic tools into clinical routine The novel biomarkers enable a better diagnosis and monit...